Home » Newsletters » BioWorld Science

BioWorld Science

Oct. 19, 2021

View Archived Issues

New vaccine targets multiple coronaviruses in mice

BGS-1989: a promising compound for treating WDR5-dependent cancers

Integrin activator 7HP-349 shows efficacy as vaccine adjuvant in model of Chagas disease

Dong-A ST patents AhR modulators

Universidade do Minho discloses new antimalarials

Janssen BioPharma presents new influenza endonuclease inhibitors

Carna Biosciences identifies hSTING antagonists

Exo Therapeutics divulges new EED inhibitors

Cannabidiol-carbamate hybrid shows therapeutic potential in models of AD

CoImmune and MSK collaborate to adapt CAR-CIK technology to treat solid tumors

Orexia and Schrodinger collaborate to discover novel therapeutics targeting OX2 receptor

CELSR2 regulates lipid homeostasis and it is a therapeutic target in NAFLD

Atsena discloses preclinical gene therapy program for X-linked retinoschisis

Hygromycin A clears B. burgdorferi infection in mice

PDE9 inhibition shows preclinical promise for the treatment of obesity and cardiometabolic syndrome

Nordic Nanovector and University of Pennsylvania establish CD37-targeting CAR-T cell collaboration

NCI awards SBIR grant to Orphagen to develop OR-449 for adrenocortical carcinoma

Enesi and NIAID enter agreement to study ImplaVax-enabled pandemic flu vaccine

Boehringer Ingelheim exercises IP options to support development of gene therapy for cystic fibrosis

BrainStorm presents preclinical data on MSC-NTF exosomes in models of acute lung injury

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 30, 2025.
Today's news in brief
Briefs
BioWorld MedTech briefs for Jan. 30, 2026.
Centessa’s CNT-9982 shows promise for MDD
BioWorld Science
Orexin OX2 receptor agonists have demonstrated the ability to enhance wakefulness in rodent models, as well as in nonhuman primates and patients with narcolepsy...
First-in-class ADC targeting DEM-TXX shows high preclinical efficacy
BioWorld Science
Researchers at DEM Biopharma Inc. reported preclinical findings demonstrating the efficacy of DEM-301, a bifunctional antibody-drug conjugate (ADC) engineered to...
5-HT2R allosteric ligands attenuate cocaine use and seeking behavior
BioWorld Science
Serotonergic G-protein-coupled receptors (GPCRs), including the 5-HT2A receptor (5-HT2AR) and 5-HT2CR, are key regulators of cortical signaling pathways and...